WallStreetZenWallStreetZen

NASDAQ: LYEL
Lyell Immunopharma Inc Stock Ownership - Who owns Lyell Immunopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lyell Immunopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David ShookChief Medical Officer2026-06-101,977$12.64
$24.99kSell
Stephen J. HillChief Operating Officer2026-05-1189$18.92
$1.68kSell
Veronica Sanchez BulisVP Corporate Controller2026-05-11217$18.91
$4.10kSell
Lynn SeelyPresident and CEO2026-05-11388$18.91
$7.34kSell
Gary K. LeeChief Scientific Officer2026-05-11130$18.92
$2.46kSell
Arch Venture Fund XIII LP10% Owner2026-03-06488,090$25.61
$12.50MBuy
Arch Venture Partners IX LLC10% Owner2026-03-06488,090$25.61
$12.50MBuy
Stephen J. HillChief Operating Officer2026-02-111,236$23.39
$28.91kSell
Gary K. LeeChief Scientific Officer2026-02-111,671$23.39
$39.08kSell
Lynn SeelyPresident and CEO2026-02-117,455$23.39
$174.37kSell

1 of 4

LYEL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYEL insiders and whales buy or sell their stock.

LYEL Shareholders

What type of owners hold Lyell Immunopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen234.07%54,619,074$695.85MInsider
Arch Venture Partners IX LLC167.75%39,143,667$498.69MInsider
Glaxosmithkline PLC129.65%30,253,189$385.43MInsider
Richard Klausner24.18%5,641,764$71.88MInsider
Hans Edgar Bishop20.08%4,685,614$59.69MInsider
Arch Venture Management LLC13.92%3,247,162$41.37MInstitution
Innovative Cellular Therapeutics Holdings Ltd12.86%3,000,000$38.22MInsider
Arch Venture Fund XIII LP7.92%1,848,755$23.55MInsider
Gsk PLC6.48%1,512,659$19.27MInstitution
Foresite Capital Management IV LLC3.43%800,399$10.20MInstitution

1 of 3

LYEL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYEL8.31%91.69%Net BuyingNet Selling
BCYC53.66%43.65%Net SellingNet Selling
NMRA30.07%69.93%Net Buying
SRZN34.48%65.52%Net BuyingNet Buying
TRDA42.64%57.36%Net SellingNet Selling
View Top Biotech Stocks

Lyell Immunopharma Stock Ownership FAQ

Who owns Lyell Immunopharma?

Lyell Immunopharma (NASDAQ: LYEL) is owned by 54.28% institutional shareholders, 599.10% Lyell Immunopharma insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Lyell Immunopharma shareholder, owning 54.62M shares representing 234.07% of the company. Robert Nelsen's Lyell Immunopharma shares are currently valued at $653.79M.

If you're new to stock investing, here's how to buy Lyell Immunopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.